Centene Climbs Higher In 2013 FORTUNE 500 Ranking
ST. LOUIS, May 6, 2013 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its position as #303 in FORTUNE Magazine's recently released annual ranking of America's largest corporations by revenue. Centene, which moved up 150 places from last year's ranking, experienced strong growth in 2012, with total revenues of $8.7 billion, up from $5.3 billion in 2011.
"Centene's position this year illustrates our expanding presence as a national leader in healthcare services," said Centene Chairman and Chief Executive Officer Michael F. Neidorff. "We have continued to advance higher in FORTUNE's annual ranking for the past several years. By offering a diverse array of solutions to improve the health of communities, one person at a time, we will continue to be well positioned to meet our growth objectives over the next several years."
In 2012, Centene was awarded nine new health plan contracts and grew its revenue by 62% over the previous year.
About Centene Corporation
Centene Corporation, a FORTUNE 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care, long-term care, other state-sponsored programs and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique "exchange-based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management. More information regarding Centene is available at www.centene.com.
SOURCE Centene Corporation
More by this Source
Centene Specialty Pharma Subsidiary Receives Full URAC Accreditation
Dec 03, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.